Kit For The Preparation Of Technetium Tc 99m Tilmanocept Injection Injection, Powder, Lyophilized, For Solution
NDC Package 73301-017-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Kit For The Preparation Of Technetium Tc 99m Tilmanocept Injection injection is a drug for further processing. This formulation utilizes a injection, powder, lyophilized, for solution delivery system. Marketed by Lsne, Inc., this product is identified by NDC 73301-017.

Identification & Billing

NDC Package Code
73301-017-01
Package Description
1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
Product Code
73301-017
11-Digit Billing Format
73301001701

Clinical Specifications

Proprietary Name
Kit For The Preparation Of Technetium Tc 99m Tilmanocept Injection
Non-Proprietary Name
Kit For The Preparation Of Technetium Tc 99m Tilmanocept Injection
Substance Name
Technetium Tc-99m Tilmanocept
Dosage Form
Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
Active Ingredient(s)
TECHNETIUM TC-99M TILMANOCEPT 250 ug/1

Regulatory & Marketing

Labeler Name
Lsne, Inc.
Product Type
Drug For Further Processing
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
12-13-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73301-017-01 identifies a specific commercial package of 1 injection, powder, lyophilized, for solution in 1 vial of Kit For The Preparation Of Technetium Tc 99m Tilmanocept Injection (UNFINISHED drug), drug for further processing labeled by Lsne, Inc.. This injection, powder, lyophilized, for solution is formulated for use and contains technetium tc-99m tilmanocept as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Lsne, Inc. on December 13, 2024. The current certification is valid through December 31, 2026.

How is this Lsne, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73301001701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73301-017-01
11-Digit CMS (5-4-2)
73301-0017-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.